UNSPSC 51343117: Idoxuridine monohydrate

This classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula C9H11IN2O5.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7E78KL7PVW, chemically known as uridine, 2'-deoxy-5-iodo-, monohydrate, but more generally known as idoxuridine monohydrate, which bears US NIH Compound Identifier 28330. European Medicines Agency schedules idoxuridine monohydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08117MIG.

Most nations, for tariff purposes, schedule idoxuridine monohydrate under HS 29349990. SMILES: C1C(C(=O)[NH]C(=O)N1[C@H]2C[C@@H]([C@H](O2)CO)O)I.O.

UNSPSC 51343117 Idoxuridine monohydrate is a Commodity code nominally covering a specific antiviral pharmaceutical, but recent state and local solicitations posted under this code show a significant scope mismatch — the opportunities actually being bought are naloxone, generic multi-source pharmaceuticals and over-the-counter products, medical and first aid supplies, and prescription fulfillment program services, bearing no relationship to the code's antiviral drug designation. The work reflects what state and local health agencies, fire departments, and cooperative purchasing alliances actually procure in pharmaceutical and emergency medical supply categories. Issuing bodies include county health departments, state health and human services commissions, municipal fire departments, and multi-state cooperative purchasing vehicles. Geographic activity centers on Florida, Texas, and Minnesota, with multi-state reach through cooperative purchasing arrangements.

Representative recent opportunities include Seminole County, Florida's June 2026 IFB (IFB60459723LAS) for 1,900 units of naloxone and 800 safe drug deactivation systems annually, due July 26, 2026; the Texas Health and Human Services Commission's April 2026 RFI (HHS0017013) exploring direct-to-manufacturer prescription programs; the City of Tampa's March 2026 IFB (26P00145) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, with an estimated contract value of $700,000 and a five percent bid discount available to certified Small Local Business Enterprises; and the Minnesota Multistate Cooperative Purchasing Alliance's January 2026 RFP (S1070000015802) for generic pharmaceuticals and OTC products available through three authorized wholesalers, with proposals due March 26, 2026. The code shows active procurement momentum across health systems, emergency services, and multi-jurisdictional cooperative vehicles, though the nominal code taxonomy does not accurately describe the pharmaceutical and medical supply work actually being solicited.